These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1507 related articles for article (PubMed ID: 24463507)

  • 1. De novo mutations in schizophrenia implicate synaptic networks.
    Fromer M; Pocklington AJ; Kavanagh DH; Williams HJ; Dwyer S; Gormley P; Georgieva L; Rees E; Palta P; Ruderfer DM; Carrera N; Humphreys I; Johnson JS; Roussos P; Barker DD; Banks E; Milanova V; Grant SG; Hannon E; Rose SA; Chambert K; Mahajan M; Scolnick EM; Moran JL; Kirov G; Palotie A; McCarroll SA; Holmans P; Sklar P; Owen MJ; Purcell SM; O'Donovan MC
    Nature; 2014 Feb; 506(7487):179-84. PubMed ID: 24463507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A polygenic burden of rare disruptive mutations in schizophrenia.
    Purcell SM; Moran JL; Fromer M; Ruderfer D; Solovieff N; Roussos P; O'Dushlaine C; Chambert K; Bergen SE; Kähler A; Duncan L; Stahl E; Genovese G; Fernández E; Collins MO; Komiyama NH; Choudhary JS; Magnusson PK; Banks E; Shakir K; Garimella K; Fennell T; DePristo M; Grant SG; Haggarty SJ; Gabriel S; Scolnick EM; Lander ES; Hultman CM; Sullivan PF; McCarroll SA; Sklar P
    Nature; 2014 Feb; 506(7487):185-90. PubMed ID: 24463508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.
    Tarabeux J; Kebir O; Gauthier J; Hamdan FF; Xiong L; Piton A; Spiegelman D; Henrion É; Millet B; ; Fathalli F; Joober R; Rapoport JL; DeLisi LE; Fombonne É; Mottron L; Forget-Dubois N; Boivin M; Michaud JL; Drapeau P; Lafrenière RG; Rouleau GA; Krebs MO
    Transl Psychiatry; 2011 Nov; 1(11):e55. PubMed ID: 22833210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.
    Kirov G; Pocklington AJ; Holmans P; Ivanov D; Ikeda M; Ruderfer D; Moran J; Chambert K; Toncheva D; Georgieva L; Grozeva D; Fjodorova M; Wollerton R; Rees E; Nikolov I; van de Lagemaat LN; Bayés A; Fernandez E; Olason PI; Böttcher Y; Komiyama NH; Collins MO; Choudhary J; Stefansson K; Stefansson H; Grant SG; Purcell S; Sklar P; O'Donovan MC; Owen MJ
    Mol Psychiatry; 2012 Feb; 17(2):142-53. PubMed ID: 22083728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity.
    Hall J; Trent S; Thomas KL; O'Donovan MC; Owen MJ
    Biol Psychiatry; 2015 Jan; 77(1):52-8. PubMed ID: 25152434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.
    Gauthier J; Siddiqui TJ; Huashan P; Yokomaku D; Hamdan FF; Champagne N; Lapointe M; Spiegelman D; Noreau A; Lafrenière RG; Fathalli F; Joober R; Krebs MO; DeLisi LE; Mottron L; Fombonne E; Michaud JL; Drapeau P; Carbonetto S; Craig AM; Rouleau GA
    Hum Genet; 2011 Oct; 130(4):563-73. PubMed ID: 21424692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo mutations in epileptic encephalopathies.
    ; ; Allen AS; Berkovic SF; Cossette P; Delanty N; Dlugos D; Eichler EE; Epstein MP; Glauser T; Goldstein DB; Han Y; Heinzen EL; Hitomi Y; Howell KB; Johnson MR; Kuzniecky R; Lowenstein DH; Lu YF; Madou MR; Marson AG; Mefford HC; Esmaeeli Nieh S; O'Brien TJ; Ottman R; Petrovski S; Poduri A; Ruzzo EK; Scheffer IE; Sherr EH; Yuskaitis CJ; Abou-Khalil B; Alldredge BK; Bautista JF; Berkovic SF; Boro A; Cascino GD; Consalvo D; Crumrine P; Devinsky O; Dlugos D; Epstein MP; Fiol M; Fountain NB; French J; Friedman D; Geller EB; Glauser T; Glynn S; Haut SR; Hayward J; Helmers SL; Joshi S; Kanner A; Kirsch HE; Knowlton RC; Kossoff EH; Kuperman R; Kuzniecky R; Lowenstein DH; McGuire SM; Motika PV; Novotny EJ; Ottman R; Paolicchi JM; Parent JM; Park K; Poduri A; Scheffer IE; Shellhaas RA; Sherr EH; Shih JJ; Singh R; Sirven J; Smith MC; Sullivan J; Lin Thio L; Venkat A; Vining EP; Von Allmen GK; Weisenberg JL; Widdess-Walsh P; Winawer MR
    Nature; 2013 Sep; 501(7466):217-21. PubMed ID: 23934111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DISC1 regulates N-methyl-D-aspartate receptor dynamics: abnormalities induced by a Disc1 mutation modelling a translocation linked to major mental illness.
    Malavasi ELV; Economides KD; Grünewald E; Makedonopoulou P; Gautier P; Mackie S; Murphy LC; Murdoch H; Crummie D; Ogawa F; McCartney DL; O'Sullivan ST; Burr K; Torrance HS; Phillips J; Bonneau M; Anderson SM; Perry P; Pearson M; Constantinides C; Davidson-Smith H; Kabiri M; Duff B; Johnstone M; Polites HG; Lawrie SM; Blackwood DH; Semple CA; Evans KL; Didier M; Chandran S; McIntosh AM; Price DJ; Houslay MD; Porteous DJ; Millar JK
    Transl Psychiatry; 2018 Sep; 8(1):184. PubMed ID: 30190480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The state of synapses in fragile X syndrome.
    Pfeiffer BE; Huber KM
    Neuroscientist; 2009 Oct; 15(5):549-67. PubMed ID: 19325170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncating variant burden in high-functioning autism and pleiotropic effects of LRP1 across psychiatric phenotypes.
    Torrico B; Shaw AD; Mosca R; Vivó-Luque N; Hervás A; Fernàndez-Castillo N; Aloy P; Bayés M; Fullerton JM; Cormand B; Toma C
    J Psychiatry Neurosci; 2019 Sep; 44(5):350-359. PubMed ID: 31094488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation.
    Berkel S; Marshall CR; Weiss B; Howe J; Roeth R; Moog U; Endris V; Roberts W; Szatmari P; Pinto D; Bonin M; Riess A; Engels H; Sprengel R; Scherer SW; Rappold GA
    Nat Genet; 2010 Jun; 42(6):489-91. PubMed ID: 20473310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability.
    Hamdan FF; Gauthier J; Araki Y; Lin DT; Yoshizawa Y; Higashi K; Park AR; Spiegelman D; Dobrzeniecka S; Piton A; Tomitori H; Daoud H; Massicotte C; Henrion E; Diallo O; ; Shekarabi M; Marineau C; Shevell M; Maranda B; Mitchell G; Nadeau A; D'Anjou G; Vanasse M; Srour M; Lafrenière RG; Drapeau P; Lacaille JC; Kim E; Lee JR; Igarashi K; Huganir RL; Rouleau GA; Michaud JL
    Am J Hum Genet; 2011 Mar; 88(3):306-16. PubMed ID: 21376300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDAR mediated translation at the synapse is regulated by MOV10 and FMRP.
    Kute PM; Ramakrishna S; Neelagandan N; Chattarji S; Muddashetty RS
    Mol Brain; 2019 Jul; 12(1):65. PubMed ID: 31291981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of de novo coding mutations to autism spectrum disorder.
    Iossifov I; O'Roak BJ; Sanders SJ; Ronemus M; Krumm N; Levy D; Stessman HA; Witherspoon KT; Vives L; Patterson KE; Smith JD; Paeper B; Nickerson DA; Dea J; Dong S; Gonzalez LE; Mandell JD; Mane SM; Murtha MT; Sullivan CA; Walker MF; Waqar Z; Wei L; Willsey AJ; Yamrom B; Lee YH; Grabowska E; Dalkic E; Wang Z; Marks S; Andrews P; Leotta A; Kendall J; Hakker I; Rosenbaum J; Ma B; Rodgers L; Troge J; Narzisi G; Yoon S; Schatz MC; Ye K; McCombie WR; Shendure J; Eichler EE; State MW; Wigler M
    Nature; 2014 Nov; 515(7526):216-21. PubMed ID: 25363768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.
    de Bartolomeis A; Latte G; Tomasetti C; Iasevoli F
    Mol Neurobiol; 2014 Feb; 49(1):484-511. PubMed ID: 23999870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of NMDAR-dependent synaptic plasticity in Fmr1 knock-out mice.
    Bostrom CA; Majaess NM; Morch K; White E; Eadie BD; Christie BR
    Cereb Cortex; 2015 Jan; 25(1):271-9. PubMed ID: 23968838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Sequencing of 10,198 Samples Confirms Abnormalities in Neuronal Activity and Implicates Voltage-Gated Sodium Channels in Schizophrenia Pathogenesis.
    Rees E; Carrera N; Morgan J; Hambridge K; Escott-Price V; Pocklington AJ; Richards AL; Pardiñas AF; ; McDonald C; Donohoe G; Morris DW; Kenny E; Kelleher E; Gill M; Corvin A; Kirov G; Walters JTR; Holmans P; Owen MJ; O'Donovan MC
    Biol Psychiatry; 2019 Apr; 85(7):554-562. PubMed ID: 30420267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders.
    Santini E; Klann E
    Sci Signal; 2014 Oct; 7(349):re10. PubMed ID: 25351249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fmr1 deficiency promotes age-dependent alterations in the cortical synaptic proteome.
    Tang B; Wang T; Wan H; Han L; Qin X; Zhang Y; Wang J; Yu C; Berton F; Francesconi W; Yates JR; Vanderklish PW; Liao L
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):E4697-706. PubMed ID: 26307763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brunner syndrome associated MAOA mutations result in NMDAR hyperfunction and increased network activity in human dopaminergic neurons.
    van Rhijn JR; Shi Y; Bormann M; Mossink B; Frega M; Recaioglu H; Hakobjan M; Klein Gunnewiek T; Schoenmaker C; Palmer E; Faivre L; Kittel-Schneider S; Schubert D; Brunner H; Franke B; Nadif Kasri N
    Neurobiol Dis; 2022 Feb; 163():105587. PubMed ID: 34923109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.